Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147

Cancer Science

Volumn 101, Issue 2, 2010, Pages 387-395

  Zhao, Pu ^a   Zhang, Wei ^b   Tang, Juan ^a   Ma, Xiao Kui ^a   Dai, Jing Yao ^b   Li, Yong ^a   Jiang, Jian Li ^a   Zhang, Si He ^a   Chen, Zhi Nan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; LIPOCORTIN 2; MATRIX METALLOPROTEINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANNEXIN A2; ANTIGENS, CD147; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS;

EID: 75649138376     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01420.x     Document Type: Article

References (42)

1. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem 2002, 277:564-70.
2. Liotta LA. Cancer cell invasion and metastasis. Sci Am 1992, 266(549):62-3.
3. Toole BP. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003, 54:371-89.
4. Biswas C, Zhang Y, DeCastro R. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-9.
5. Yan L, Zucker S, Toole BP. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005, 93:199-204.
6. Chen ZN, Liu YF. Monoclonal antibody HAb18 to human hepatoma. Monoclonal Antibodies 1990, 8.
7. Liu YF, Chen ZN, Ji YY. Localization of hepatocellular carcinoma with monoclonal antibodies. Zhonghua Yi Xue Za Zhi 1991, 71:362-5.
8. Chen ZN, Xing JL, Zhang SH. Anti-human hepatoma monoclonal antibody HAb18 light/heavy chain variable region gene, and use thereof. inventors; NTD Patent & Trademark Agency. Beijing office, assignee, Chinese patent ZL02114471.0, 2002 March 15; PCT international patent WO03/078469; 2003 March 17
9. Chen ZN, Shang P, Li Y, Qian AR, Zhu P, Xing JL. HAb18G/CD147, its agonist and application. inventors; NTD Patent & Trademark Agency. Beijing office, assignee, Chinese patent ZL01131735.3, 2001 Sep 28; PCT international patent WO02/094875; 2002 May 27
10. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN, Chan HC. The involvement of HAb18G/CD147 in regulation of store-operated calcium entry and metastasis of human hepatoma cells. J Biol Chem 2001, 276:870-7.
11. Jiang JL, Chan HC, Zhou Q. HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains. Cell Mol Life Sci 2004, 61:2083-91.
12. Chen ZN, Mi L, Xu J. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys 2006, 65:435-44.
13. Xu J, Xu HY, Zhang Q. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 2007, 5:605-14.
14. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-95.
15. Stack MS, Gately S, Bafetti LM, Enghild JJ, Soff GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem J 1999, 340(Pt 1):77-84.
16. Brownstein C, Deora AB, Jacovina AT. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood 2004, 103:317-24.
17. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 2006, 81:146-56.
18. Sharma MC, Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007, 13:3568-75.
19. Hayes MJ, Shao D, Bailly M, Moss SE. Regulation of actin dynamics by annexin 2. EMBO J 2006, 25:1816-26.
20. Hayes MJ, Merrifield CJ, Shao D. Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway. J Biol Chem 2004, 279(14):157-64.
21. Singh P. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Cancer Lett 2007, 252:19-35.
22. Mussunoor S, Murray GI. The role of annexins in tumour development and progression. J Pathol 2008, 216:131-40.
23. Liu JW, Shen JJ, Tanzillo-Swarts A. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003, 22:1475-85.
24. Hastie C, Masters JR, Moss SE, Naaby-Hansen S. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells. J Biol Chem 2008, 283:595-603.
25. Lou CY, Feng YM, Qian AR. Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. World J Gastroenterol 2004, 10:1462-5.
26. Li Y, Tang ZY, Ye SL. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001, 7:630-6.
27. Suzuki S, Sato M, Senoo H, Ishikawa K. Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Exp Cell Res 2004, 293:259-66.
28. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002, 99:520-8.
29. Bordador LC, Li X, Toole B. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 2000, 85:347-52.
30. Jiang JL, Tang J. CD147 and its interacting proteins in cellular functions. Sheng Li Xue Bao 2007, 59:517-23.
31. Xu HY, Qian AR, Shang P. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway. Cancer Lett 2007, 247:336-44.
32. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL, Chen ZN. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca(2+) pathways. Cell Mol Life Sci 2008, 65:2933-42.
33. Qian AR, Zhang W, Cao JP. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2008, 27:50.
34. Rescher U, Ruhe D, Ludwig C, Zobiack N, Gerke V. Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J Cell Sci 2004, 117:3473-80.
35. Merrifield CJ, Rescher U, Almers W. Annexin 2 has an essential role in actin-based macropinocytic rocketing. Curr Biol 2001, 11:1136-41.
36. Zobiack N, Rescher U, Laarmann S, Michgehl S, Schmidt MA, Gerke V. Cell-surface attachment of pedestal-forming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J Cell Sci 2002, 115:91-8.
37. Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem 1995, 270:780-7.
38. Curtin KD, Meinertzhagen IA, Wyman RJ. Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture. J Cell Sci 2005, 118:2649-60.
39. MacLeod TJ, Kwon M, Filipenko NR, Waisman DM. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem 2003, 278:577-84.
40. Waisman DM. Annexin II tetramer: structure and function. Mol Cell Biochem 1995, 149-150:301-22.
41. Carmeliet P, Moons L, Lijnen R. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997, 17:439-44.
42. McColl BK, Baldwin ME, Roufail S. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 2003, 198:863-8.